News

SIFI Unveils Innovations at Renowned Cataract Surgery Congress

SIFI Unveils Innovations at Renowned Cataract Surgery Congress

SIFI Showcases Innovative Solutions at Major Congress

SIFI, a leading international ophthalmic company, is thrilled to announce its participation in a significant medical event where it will unveil two groundbreaking product innovations along with fresh scientific evidence. This event, the Congress of The European Society of Cataract and Refractive Surgeons (ESCRS), is a vital platform for discussing advancements in cataract and refractive surgery.

Transformative Products for Enhanced Patient Care

In line with its dedication to healthcare excellence, SIFI is introducing new technologies aimed at improving surgical outcomes. Maria Cristina Curatolo, SIFI's Executive Director of Innovation and Medical Science, highlights the integration of wavefront technology with ocular surface management, marking a significant advancement in refractive cataract procedures. These innovations are designed to help patients achieve better vision quality.

Revamped Intraocular Lens Innovations

SIFI will present an enhanced version of its EVOLUX extended monofocal intraocular lens (IOL), featuring upgraded delivery technology. This new design allows surgeons the flexibility to use either a push or screw technique during implantation, making the process more adaptable.

Next-Generation IOL Calculator

Additionally, SIFI will introduce a new IOL calculator that utilizes Hoffer QST and Næser-Savini formulas, significantly improving the accuracy of calculating both spherical and cylindrical lens powers, further enhanced by artificial intelligence applications.

Scientific Presentations Focus on Clinical Outcomes

The Congress will include five podium presentations and an equal number of e-Posters that delve into SIFI’s solutions for cataract surgery and ocular surface diseases. Among the topics presented will be the performance of the EVOLUX lens, the presbyopia-correcting WELL FUSION system, and the advantages of Eyestil SYNFO artificial tears.

Overview of Podium Sessions

On Sunday, a series of e-Poster presentations will explore various aspects of visual performance and patient satisfaction across different IOLs and treatments. Key studies include:

  • Comparative studies on visual acuity with monofocal IOLs (Pagnacco C.)
  • Research on preservative-free ophthalmic solutions for eye discomfort (Molero-Senosiain M.)
  • Refractive outcomes from the use of enhanced monofocal lenses (Romualdi G.)
  • Visual acuity evaluations of non-diffractive lens technologies (Rotter A.)

Details on Free Paper Session

A crucial free paper session is planned, focusing on a randomized clinical trial that compares the effectiveness of extended depth of focus IOLs with trifocal IOLs, offering insights into patient quality of life following surgery (Pagnacco C.).

Announcing the Satellite Symposium

Separately, SIFI is hosting a Satellite Symposium titled "Ultimate Vision: Mastering Sight with Wavefront Engineering and Innovative Ocular Surface Management." This event will feature leading experts discussing the latest advancements in the field.

Comprehensive e-Poster List

Alongside podium presentations, attendees can look forward to a diverse range of e-Posters, including research on:

  • Outcomes of enhanced monofocal IOLs (Savini G.)
  • Long-term visual performance of EVOLUX lenses after cataract surgery (Caparas V.)
  • Comparative studies on advanced monofocal IOLs from SIFI (Gabri? K.)
  • Insights into binocular vision impacts from various intraocular lens technologies (Castanera D.)
  • Clinical validation concerning wavefront engineering technology (Vacalebre M.)

About SIFI

Established in 1935, SIFI is at the forefront of ophthalmic innovation, boasting a comprehensive model that includes research, development, manufacturing, and commercialization within the pharmaceutical and biomedical sectors. Our mission is to enhance lives through impactful eye care innovations. SIFI operates in over 40 countries, maintaining a strong presence in major European markets, Mexico, and fostering partnerships in China and the United Arab Emirates.

Frequently Asked Questions

What is the significance of SIFI's presence at the ESCRS Congress?

SIFI's participation in the Congress underscores its dedication to advancing cataract surgery and improving patient care through innovative technologies and research findings.

What new products will SIFI introduce?

SIFI will unveil an upgraded version of its EVOLUX intraocular lens and a new IOL calculator, both aimed at enhancing surgical precision and outcomes.

When will the scientific presentations take place?

The presentations will occur on various dates throughout the Congress, with specific sessions scheduled for Sunday and Tuesday.

What are some key topics covered in the presentations?

Topics will include visual performance, patient satisfaction, outcomes of different IOL technologies, and treatments for ocular surface diseases.

How can the public learn more about SIFI's innovations?

For more information, visit SIFI's official website, which provides details about their products, research, and ongoing commitments to eye care innovation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 104

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 116

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 160

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 119

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 178

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 74

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading

Top 5 Most Recently Viewed Articles

Denali's Remarkable Impact: 14 Billion Pounds of Recycling Triumph

Updated Category News Views 99

Denali's Massive Recycling Achievement Denali, a leader in the organic recycling sector, has made headlines with its extraordinary accomplishment of recycling 14 billion pounds of organic materials and byproducts in just one year. This remarkable feat, outlined in its latest annual sustainability report, showcases Denali's dedication to advancing sustainability and...

Continue Reading
Prologis Set to Reveal Fourth Quarter Insights in Early 2026

Updated Category News Views 221

Prologis to Release Fourth Quarter Results Prologis, Inc. (NYSE: PLD), a major player in logistics real estate, is preparing to announce its fourth quarter results. This essential event will take place in early January 2026, providing a valuable opportunity for investors and stakeholders to gain insights into the company's performance and future direction. Details of the...

Continue Reading
Joel Hodgson Reveals Insights on Creativity in Exclusive Podcast

Updated Category News Views 163

Exclusive Insights from Joel Hodgson In the latest episode of Edge of Cinema's podcast Stories From the Top, the renowned creator of Mystery Science Theater 3000 (MST3K), Joel Hodgson, shares his remarkable journey as a comedian and innovator. Known for his passion for creativity, this episode takes listeners on a fascinating adventure through Hodgson's early interests in...

Continue Reading
Mo3 Estate Triumphs Over Sound Engineer in Copyright Case

Updated Category News Views 513

Mo3 Estate's Landmark Copyright Lawsuit Victory The Estate of Melvin Noble, Jr., known worldwide as the celebrated artist Mo3, has achieved a major win against former sound engineer Ray Gene Bollin, Jr. This case, which revolved around crucial allegations of copyright infringement and other claims, underscores a pivotal moment not just for Mo3, but for artists everywhere....

Continue Reading
Monetary Gold: A Quarter-Century of Trust in Precious Metals

Updated Category News Views 147

Monetary Gold: A Foundation of Trust For over 25 years, Monetary Gold has been a beacon of trust and stability in the precious metals industry. The firm's commitment to clients and resilience through various economic challenges highlights its dedication to providing peace of mind for investors. Celebrating a Legacy of Integrity Since its establishment, Monetary Gold has...

Continue Reading